Insider · CIK 0001239312
Sean Carney
Files at BBNX (Beta Bionics, Inc.). First filing -, latest -.
In brief
Sean Carney files SEC Form 4 as director at BBNX (Beta Bionics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Sean Carney has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | BBNX Beta Bionics, Inc. | AGrant or award Common Stock | +16,965 | $0.00 | $0 | 32,209 | May 26, 2026 |
| Jan 13, 2026 | BBNX Beta Bionics, Inc. | AGrant or award Common Stock | +3,997 | $0.00 | $0 | 15,244 | Jan 14, 2026 |
| Mar 15, 2025 | BBNX Beta Bionics, Inc. | AGrant or award Common Stock | +11,247 | $0.00 | $0 | 11,247 | Mar 18, 2025 |
| Jan 31, 2025 | BBNX Beta Bionics, Inc. | AGrant or award Director Stock Option (right to buy)derivative | +55,837 | $0.00 | $0 | 55,837 | Feb 3, 2025 |
| Jan 31, 2025 | BBNX Beta Bionics, Inc. | AGrant or award Director Stock Option (right to buy)derivative | +30,456 | $0.00 | $0 | 30,456 | Feb 3, 2025 |
Questions about Sean Carney
Answered from the filings on this page, as of the latest one.
Is Sean Carney buying or selling?
Sean Carney has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Sean Carney's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sean Carney has 0.
Where does Sean Carney file Form 4?
Sean Carney has filed Form 4 at BBNX (Beta Bionics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.